News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,096 Results
Type
Article (8394)
Company Profile (112)
Press Release (277581)
Multimedia
Podcasts (3)
Webinars (5)
Section
Business (83052)
Career Advice (659)
Deals (16883)
Drug Delivery (9)
Drug Development (37880)
Employer Resources (49)
FDA (5296)
Job Trends (5802)
News (144174)
Policy (11402)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (741)
Accelerated approval (13)
Allergies (72)
Alliances (21490)
ALS (84)
Alzheimer's disease (676)
Antibody-drug conjugate (ADC) (162)
Approvals (5627)
Artificial intelligence (188)
Autoimmune disease (83)
Automation (13)
Bankruptcy (113)
Best Places to Work (5021)
BIOSECURE Act (3)
Biosimilars (109)
Biotechnology (75)
Bladder cancer (95)
Brain cancer (25)
Breast cancer (253)
Cancer (2166)
Cardiovascular disease (129)
Career advice (583)
Career pathing (15)
CAR-T (109)
CDC (3)
Cell therapy (261)
Cervical cancer (14)
Clinical research (34269)
Collaboration (818)
Compensation (702)
Complete response letters (16)
COVID-19 (768)
CRISPR (26)
C-suite (428)
Cystic fibrosis (48)
Data (3204)
Denatured (2)
Depression (76)
Diabetes (191)
Diagnostics (1826)
Digital health (19)
Diversity (2)
Diversity, equity & inclusion (12)
Drug discovery (94)
Drug pricing (24)
Drug shortages (4)
Duchenne muscular dystrophy (103)
Earnings (38179)
Editorial (7)
Employer branding (6)
Employer resources (47)
Events (49579)
Executive appointments (495)
FDA (6878)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (2)
Frontotemporal dementia (14)
Funding (598)
Gene editing (56)
Generative AI (13)
Gene therapy (152)
GLP-1 (294)
Government (1120)
Grass and pollen (1)
Guidances (216)
Healthcare (5979)
HIV (28)
Huntington's disease (9)
IgA nephropathy (38)
Immunology and inflammation (56)
Immuno-oncology (20)
Indications (72)
Infectious disease (859)
Inflammatory bowel disease (90)
Inflation Reduction Act (1)
Influenza (47)
Intellectual property (117)
Interviews (108)
IPO (8697)
IRA (8)
Job creations (1015)
Job search strategy (496)
JPM (7)
Kidney cancer (10)
Labor market (17)
Layoffs (97)
Leadership (16)
Legal (2566)
Liver cancer (44)
Longevity (5)
Lung cancer (320)
Lymphoma (183)
Machine learning (17)
Management (19)
Manufacturing (323)
MASH (97)
Medical device (4119)
Medtech (4144)
Mergers & acquisitions (8900)
Metabolic disorders (468)
mRNA (21)
Multiple sclerosis (81)
NASH (8)
Neurodegenerative disease (106)
Neuropsychiatric disorders (31)
Neuroscience (1261)
NextGen: Class of 2026 (2094)
Non-profit (1426)
Now hiring (6)
Obesity (166)
Opinion (66)
Ovarian cancer (56)
Pain (79)
Pancreatic cancer (107)
Parkinson's disease (123)
Partnered (13)
Patents (211)
Patient recruitment (259)
Peanut (24)
People (23974)
Pharmaceutical (36)
Pharmacy benefit managers (4)
Phase 1 (10145)
Phase 2 (15308)
Phase 3 (11547)
Pipeline (3058)
Policy (42)
Postmarket research (769)
Preclinical (3792)
Press Release (18)
Prostate cancer (87)
Psychedelics (6)
Radiopharmaceuticals (140)
Rare diseases (349)
Real estate (1975)
Recruiting (22)
Regulatory (9622)
Reports (21)
Research institute (631)
Resumes & cover letters (82)
Rett syndrome (6)
RNA editing (3)
RSV (21)
Schizophrenia (111)
Series A (95)
Series B (75)
Service/supplier (6)
Sickle cell disease (31)
Spinal muscular atrophy (48)
Sponsored (10)
Startups (1343)
State (1)
Stomach cancer (3)
Supply chain (33)
Tariffs (10)
The Weekly (1)
Vaccines (250)
Venture capital (20)
Weight loss (49)
Women's health (25)
Worklife (9)
Date
Last 7 days (449)
Last 30 days (1239)
Last 365 days (14633)
2026 (2324)
2025 (14782)
2024 (17070)
2023 (19808)
2022 (25010)
2021 (27102)
2020 (24545)
2019 (18792)
2018 (13681)
2017 (13794)
2016 (12222)
2015 (15077)
2014 (11378)
2013 (8627)
2012 (8773)
2011 (8773)
2010 (8242)
Location
Africa (236)
Alabama (31)
Alaska (2)
Arizona (75)
Arkansas (6)
Asia (30145)
Australia (3821)
California (5643)
Canada (1468)
China (902)
Colorado (205)
Connecticut (324)
Delaware (210)
Europe (39696)
Florida (831)
Georgia (176)
Idaho (10)
Illinois (375)
India (44)
Indiana (176)
Iowa (16)
Japan (326)
Kansas (80)
Kentucky (17)
Louisiana (8)
Maine (19)
Maryland (609)
Massachusetts (4326)
Michigan (84)
Minnesota (244)
Mississippi (4)
Missouri (69)
Montana (1)
Nebraska (11)
Nevada (35)
New Hampshire (19)
New Jersey (1822)
New Mexico (6)
New York (1793)
North Carolina (709)
Northern California (2868)
Ohio (128)
Oklahoma (10)
Oregon (15)
Pennsylvania (1066)
Puerto Rico (5)
Rhode Island (22)
South America (326)
South Carolina (10)
Southern California (2250)
Tennessee (40)
Texas (822)
United States (20220)
Utah (151)
Virginia (218)
Washington D.C. (28)
Washington State (360)
West Virginia (2)
Wisconsin (44)
286,096 Results for "suzhou connect biopharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
·
1 min read
Press Releases
Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory
October 31, 2025
·
2 min read
Press Releases
Transactions in Connection with Share Buy-back Program
February 23, 2026
·
3 min read
Press Releases
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
February 11, 2026
·
4 min read
Press Releases
Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Advanced Amortisation of the First Tranche Bonds
August 7, 2025
·
4 min read
IN PARTNERSHIP WITH PII
Work Smart, Build Trust: Connecting Technology, Patient Compliance and Data Processing
In this episode presented by PII, BioSpace’s head of insights discusses decentralized clinical studies and how connected technology can improve patient compliance with guests Oliver Eden and Travis Webb.
October 16, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
January 12, 2026
·
9 min read
Press Releases
TrialAssure to Lead Discussions on CCI and Smart Anonymization at PHUSE US Connect 2026 in Austin
February 23, 2026
·
1 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
·
3 min read
Press Releases
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
February 5, 2026
·
4 min read
1 of 28,610
Next
